China SXT Pharmaceuticals Holds Shareholder Meeting
Ticker: SXTC · Form: 6-K · Filed: Jul 29, 2025 · CIK: 1723980
| Field | Detail |
|---|---|
| Company | China Sxt Pharmaceuticals, Inc. (SXTC) |
| Form Type | 6-K |
| Filed Date | Jul 29, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-meeting, corporate-governance, filing
TL;DR
SXT met with shareholders on 7/28, but details are scarce.
AI Summary
China SXT Pharmaceuticals, Inc. held a special shareholder meeting on July 28, 2025, in Taizhou, Jiangsu, China. A total of 39,648,847 ordinary shares were voted out of 116,027,758 shares outstanding.
Why It Matters
This filing indicates a formal shareholder gathering, which is a standard corporate governance event, but provides no details on the outcomes or specific resolutions discussed.
Risk Assessment
Risk Level: low — The filing is a routine report of a shareholder meeting with no indication of financial distress or significant operational changes.
Key Numbers
- 39,648,847 — Shares Voted (Represents the total number of ordinary shares that participated in the shareholder meeting.)
- 116,027,758 — Shares Outstanding (Indicates the total number of ordinary shares eligible to vote at the meeting.)
Key Players & Entities
- China SXT Pharmaceuticals, Inc. (company) — Registrant
- July 28, 2025 (date) — Shareholder meeting date
- 39,648,847 (dollar_amount) — Number of ordinary shares voted
- 116,027,758 (dollar_amount) — Total ordinary shares outstanding
FAQ
What was the purpose of the special shareholder meeting held on July 28, 2025?
The filing states that the meeting was a 'Submission of Matters to a Vote of Security Holders' but does not specify the exact matters.
What percentage of outstanding shares were represented at the meeting?
Approximately 34.17% of the 116,027,758 outstanding shares, or 39,648,847 shares, were voted.
Where was the special shareholder meeting held?
The meeting was held at 178 Taidong Road North, Taizhou, Jiangsu, People's Republic of China.
Does the company file annual reports under Form 20-F or 40-F?
The company indicates it files annual reports under cover of Form 20-F.
What is the company's standard industrial classification?
The company's standard industrial classification is 'PHARMACEUTICAL PREPARATIONS [2834]'.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 29, 2025 regarding China SXT Pharmaceuticals, Inc. (SXTC).